Antioxidant composition for the treatment of psoriasis and related diseases
Patent 6011067 Issued on January 4, 2000. Estimated Expiration Date: 
June 11, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 11, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesComposition for relief of arthritis-induced symptoms Smoking products containing antioxidants Intra-oral antioxidant preparations Antioxidant preparation Patent #: 5922346 InventorAssigneeApplicationNo. 329849 filed on 06/11/1999US Classes:514/562, Sulfur nonionically bonded424/49, DENTIFRICES (INCLUDES MOUTH WASH)424/54, Ammonia, amine, or derivative thereof (e.g., urea, etc.)424/439, Food or edible as carrier for pharmaceutical424/440, Candy, candy coated or chewing gum424/441, Chewable tablet or wafer424/464, Tablets, lozenges, or pills424/702, Selenium or compound thereof514/162, With organic nitrogen containing compound514/165, Aspirin per se (i.e., 2-(acetyloxy)benozic acid)514/171, With additional active ingredient514/474, Ascorbic acid or derivative (e.g., vitamin C, etc.)514/627, Carbon to carbon unsaturation in R604/58Powder dispenserExaminersPrimary: MacMillan, Keith D.Assistant: Kim, Vickie Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/195AbstractThe present invention deals with the combination of several synergistic antioxidants including enzymatic co-factors as adjuncts to therapy of desquamating inflammatory disorders, such as psoriasis. These topical compositions are aimed to neutralize free radical species generated by such inflammatory conditions which are responsible for certain clinical signs and symptoms. As such, damage to skin causing destruction of elastin and collagen tissues is reduced. The present synergistic antioxidants may be combined with anti-inflammatories, including corticosteroids, anti-microbials, including zinc pyrithione, and other preparations useful in the therapy of desquamating disorders as psoriasis, seborrhoeic dermatitis and related skin and scalp conditions.Field of SearchSulfur nonionically bondedNitrogen other than as nitro or nitroso nonionically bonded Carbon to carbon unsaturation in R With organic nitrogen containing compound Aspirin per se (i.e., 2-(acetyloxy)benozic acid) Food or edible as carrier for pharmaceutical Candy, candy coated or chewing gum Ammonia, amine, or derivative thereof (e.g., urea, etc.) | |
